Skip to content

Philippe Gabríel Steg

Brigham and Women's Hospital

6 papers in the Anchorcite directory, published between 2007 and 2018, cited 36,969 times in total.

ORCID profile

Research topics

Frequent co-authors

Papers

  1. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal · 2017 · 10,161 citations

    The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website www.escardio.org/guidelines For the Web Addenda which include background information and detailed discussion of the data that have provided the basis for…

  2. Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations

    BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…

  3. Fourth universal definition of myocardial infarction (2018)European Heart Journal · 2018 · 6,098 citations

    ... ... ... ... In the late 19th century, post-mortem examinations demonstrated a possible relationship between thrombotic occlusion of a coronary artery and myocardial infarction (MI).1 However, it was not until the beginning of the 20th century that the first…

  4. Clinical End Points in Coronary Stent TrialsCirculation · 2007 · 5,502 citations

    BACKGROUND: Although most clinical trials of coronary stents have measured nominally identical safety and effectiveness end points, differences in definitions and timing of assessment have created confusion in interpretation. METHODS AND RESULTS: The Academic Research Consortium is an informal collaboration…

  5. Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation · 2011 · 4,572 citations

    HomeCirculationVol. 123, No. 23Standardized Bleeding Definitions for Cardiovascular Clinical Trials Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplementary MaterialsFree AccessResearch ArticlePDF/EPUBStandardized Bleeding Definitions for Cardiovascular Clinical TrialsA Consensus Report From…

  6. Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNew England Journal of Medicine · 2018 · 3,463 citations

    BACKGROUND: Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events. METHODS: We performed a…

Metadata from OpenAlex (CC0).